Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability

Sex Difference in Formation of Propofol Metabolites: A Replication Study

(2013) Eva Choong et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Association of the CYP2B6 c.516G>T Polymorphism with High Blood Propofol Concentrations in Women from Northern Greece

(2013) Orthodoxia Mastrogianni et al.   Drug Metabolism and Pharmacokinetics

Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age

(2011) Fumiyasu Kansaku et al.   Drug Metabolism and Pharmacokinetics

Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia

(2011) Irena Loryan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Polymorphic Drug Metabolism in Anaesthesia

(2009) Juan Restrepo et al.   CURRENT DRUG METABOLISM

CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme

(2008) Hongbing Wang et al.   CURRENT DRUG METABOLISM

Aberrant Splicing Caused by Single Nucleotide Polymorphism c.516G>T [Q172H], a Marker of CYP2B6*6, Is Responsible for Decreased Expression and Activity of CYP2B6 in Liver

(2008) M. H. Hofmann et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Association between GSTP1 gene polymorphism and serum α-GST concentrations undergoing sevoflurane anaesthesia

(2007) C. Kaymak et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Involvement of human liver cytochrome P4502B6in the metabolism of propofol

(2003) Yutaka Oda et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY